Cognate BioServices Acquires Cobra Biologics

Cobra Biologics is an international advanced therapy CDMO with GMP approved facilities in both Sweden and the UK each with an extensive track record in serving our global client base. Cobra Biologics offers a broad range of integrated and stand-alone services for both the clinical and commercial markets. As a trusted provider and a key partner in the drug development and commercialization process, Cobra Biologics takes pride in manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries.